Hydrophilic Matrix Tablets for Oral Controlled Release

[1]  C. Toal.  Formulation Dependent Pharmacokinetics—Does the Dosage Form Matter for Nifedipine? , 2004, Journal of cardiovascular pharmacology.

[2]  R. Mann,et al.  United Kingdom experience with alendronate and oesophageal reactions. , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  Yoshinori Masuda,et al.  Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers. , 2004, Journal of pharmaceutical sciences.

[4]  W. Krauwinkel,et al.  Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation , 2005 .

[5]  A. Nokhodchi,et al.  The Influence of Sodium Carboxymethylcellulose on Drug Release from Polyethylene Oxide Extended Release Matrices , 2011, AAPS PharmSciTech.

[6]  W. Krauwinkel,et al.  The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS , 2005 .

[7]  Santi,et al.  Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. , 2000, Pharmaceutical science & technology today.

[8]  A. Serajuddin,et al.  Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid, theophylline, and benzoic acid. , 1985, Journal of pharmaceutical sciences.

[9]  A. Gazzaniga,et al.  Evaluation of hot-melt extrusion technique in the preparation of HPC matrices for prolonged release. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  J. Dressman,et al.  Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  J. Virjee,et al.  The Effect of Size and Shape of Tablets on Their Esophageal Transit , 1986, Journal of clinical pharmacology.

[12]  Martyn C. Davies,et al.  Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices , 1995 .

[13]  R. Conradi,et al.  The Influence of Peptide Structure on Transport Across Caco-2 Cells , 1991, Pharmaceutical Research.

[14]  N A Peppas,et al.  Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethyl cellulose matrices containing a soluble drug. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  L. Hammett.  THE THEORY OF ACIDITY , 1928 .

[16]  John E. Hogan,et al.  The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrix tablets , 1990 .

[17]  S. Singh,et al.  Facts, fallacies and future of dissolution testing of polysaccharide based colon-specific drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[18]  G. K. Jani,et al.  Pharmaceutical applications of various natural gums, mucilages and their modified forms. , 2013, Carbohydrate polymers.

[19]  U Conte,et al.  Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. , 1996, Biomaterials.

[20]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[21]  C. Melia,et al.  Molecular and mechanical properties of hydroxypropyl methylcellulose solutions during the sol:gel transition , 2009 .

[22]  H. Stevens,et al.  In Vivo Performance of an Oral MR Matrix Tablet Formulation in the Beagle Dog in the Fed and Fasted State: Assessment of Mechanical Weakness , 2008, Pharmaceutical Research.

[23]  Ping Gao,et al.  Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets , 1996 .

[24]  I Larzillière,et al.  [Esophagitis associated with the use of alendronate]. , 1999, Gastroenterologie clinique et biologique.

[25]  A. Rajabi-Siahboomi,et al.  Properties and Applications of Polyethylene Oxide and Ethylcellulose for Tamper Resistance and Controlled Drug Delivery , 2013 .

[26]  T. Vandamme,et al.  The use of polysaccharides to target drugs to the colon , 2002 .

[27]  Weiqin Tong,et al.  Application of melt granulation technology using twin-screw extruder in development of high-dose modified-release tablet formulation. , 2011, Journal of pharmaceutical sciences.

[28]  R. Fassihi,et al.  Determination of Continuous Changes in the Gel Layer Thickness of Poly(ethylene oxide) and HPMC Tablets Undergoing Hydration: A Texture Analysis Study , 1998, Pharmaceutical Research.

[29]  A. Nokhodchi,et al.  Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices , 2008, Acta pharmaceutica.

[30]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[31]  D. Barrett,et al.  Drug release from HPMC matrices in milk and fat-rich emulsions. , 2011, Journal of pharmaceutical sciences.

[32]  P. Giunchedi,et al.  Hydrophilic matrices for the extended release of a model drug exhibiting pH-dependent solubility , 1992 .

[33]  H. Lennernäs,et al.  Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man , 1995, Pharmaceutical Research.

[34]  S. Pedersen,et al.  Food induced changes in theophylline absorption from a once-a-day theophylline product. , 1986, British journal of clinical pharmacology.

[35]  S. Higuchi,et al.  Gastric pH profiles of beagle dogs and their use as an alternative to human testing. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  G. Grass,et al.  Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.

[37]  J. Koenig,et al.  The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[39]  H. Lennernäs,et al.  Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine , 2003, The Journal of pharmacy and pharmacology.

[40]  S. Badawy,et al.  Microenvironmental pH modulation in solid dosage forms. , 2007, Journal of pharmaceutical sciences.

[41]  W. Kulicke,et al.  Rheological characterization of the dilatant flow behavior of highly substituted hydroxypropylmethyl- cellulose solutions in the presence of sodium lauryl sulfate , 1998 .

[42]  T. Higuchi.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[43]  Ya‐Jane Wang,et al.  Sustained release properties of cross‐linked corn starches with varying amylose contents in monolithic tablets , 2010 .

[44]  G. Tzortzis,et al.  CLSM method for the dynamic observation of pH change within polymer matrices for oral delivery. , 2013, Biomacromolecules.

[45]  T. W. Schwarz,et al.  The effect of certain additives on the gel point of methylcellulose. , 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[46]  P. Kulinowski,et al.  Novel Application of MRI Technique Combined with Flow-Through Cell Dissolution Apparatus as Supportive Discriminatory Test for Evaluation of Controlled Release Formulations , 2010, AAPS PharmSciTech.

[47]  Waseem Kaialy,et al.  The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus. , 2013, Colloids and surfaces. B, Biointerfaces.

[48]  A. Basit,et al.  Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.

[49]  D. Grasela,et al.  Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug. , 2013, Journal of pharmaceutical sciences.

[50]  M. Williams,et al.  Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts , 1993 .

[51]  J. Williams.  Drug-induced oesophageal injury. , 1979, British medical journal.

[52]  Sergei G. Kazarian,et al.  “Chemical Photography” of Drug Release , 2003 .

[53]  S. Aoki,et al.  Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release , 1993 .

[54]  M. Nakano,et al.  Preparation and evaluation of sustained release tablets prepared with alpha-starch. , 1987, Chemical & pharmaceutical bulletin.

[55]  J. Siepmann,et al.  Predicting drug release from HPMC/lactose tablets. , 2013, International journal of pharmaceutics.

[56]  V. Sovilj,et al.  Interaction and phase separation in the system HPMC/NaCMC/SDS , 2007 .

[57]  O. H. Chan,et al.  Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans , 1995, Pharmaceutical Research.

[58]  James A. Rogers,et al.  Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test , 1997 .

[59]  M. Speakman,et al.  Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract , 2006, Current medical research and opinion.

[60]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[61]  Hoo-Kyun Choi,et al.  Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex. , 2008, International journal of pharmaceutics.

[62]  P. Paronen,et al.  Starch acetate as a tablet matrix for sustained drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[63]  N. Sarkar.  Thermal gelation properties of methyl and hydroxypropyl methylcellulose , 1979 .

[64]  Y. Qiu,et al.  Design of pH-independent controlled release matrix tablets for acidic drugs. , 2003, International journal of pharmaceutics.

[65]  A. Nokhodchi,et al.  Compression Properties of Methylcellulose and Hydroxypropylmethylcellulose Polymers , 1999 .

[66]  J. Cui,et al.  Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. , 1999, Drug development and industrial pharmacy.

[67]  Ping Gao,et al.  Diffusion in HPMC Gels. II. Prediction of Drug Release Rates from Hydrophilic Matrix Extended-Release Dosage Forms , 1995, Pharmaceutical Research.

[68]  Jennifer B Dressman,et al.  Use of the BioDis to generate a physiologically relevant IVIVC. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[69]  A. Hussain,et al.  Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices. , 1998, Journal of pharmaceutical sciences.

[70]  S. Joshi,et al.  Influence of surfactant properties on thermal behavior and sol–gel transitions in surfactant-HPMC mixtures , 2009 .

[71]  Koichiro Tahara,et al.  Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910 , 1995 .

[72]  Feng Zhang,et al.  Properties of Hot-Melt Extruded Theophylline Tablets Containing Poly(Vinyl Acetate) , 2000, Drug development and industrial pharmacy.

[73]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[74]  Bruno C. Hancock,et al.  The influence of measurement conditions on the Hammett acidity function of solid pharmaceutical excipients. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  I. Wilding,et al.  The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms , 1992 .

[76]  David E. Martin,et al.  An Oral Human Drug Absorption Study to Assess the Impact of Site of Delivery on the Bioavailability of Bevirimat , 2009, Journal of clinical pharmacology.

[77]  F. Štěpánek,et al.  Modelling of pharmaceutical tablet swelling and dissolution using discrete element method , 2012 .

[78]  R. Cameron,et al.  Magnetic resonance imaging and X-ray microtomography studies of a gel-forming tablet formulation. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[79]  M. H. Rubinstein,et al.  Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose. , 1999, Pharmaceutical development and technology.

[80]  S. Kiil,et al.  Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[81]  I. Wilding,et al.  Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.

[82]  P. Kearney,et al.  The effects of mucus glycoproteins on the bioavailability of tetracycline: I: Dissolution rate , 1986 .

[83]  S. Badawy,et al.  Effect of Processing and Formulation Variables on the Stability of a Salt of a Weakly Basic Drug Candidate , 2005, Pharmaceutical development and technology.

[84]  L. Rakesh,et al.  Monovalent and divalent salt effects on thermogelation of aqueous hypromellose solutions , 2014 .

[85]  K. Mäder,et al.  Structure and hydration properties of hydroxypropyl methylcellulose matrices containing naproxen and naproxen sodium. , 2000, International journal of pharmaceutics.

[86]  A. Karim,et al.  Food‐induced changes in theophylline absorption from controlled‐release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo‐Dur Sprinkle , 1985, Clinical pharmacology and therapeutics.

[87]  N. Peppas,et al.  Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[88]  Feng Zhang,et al.  Properties of sustained-release tablets prepared by hot-melt extrusion. , 1999, Pharmaceutical development and technology.

[89]  Clive G. Wilson,et al.  Radiolabelling of polymer microspheres for scintigraphic investigations by neutron activation. 2. Effects of irradiation on the properties of Eudragit RS-sulphasalazine microspheres , 1993 .

[90]  M. Repka,et al.  Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[91]  S. Baumgartner,et al.  Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[92]  J. Dressman,et al.  Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies , 2006, Pharmaceutical Research.

[93]  A Semi-mechanistic Modeling Strategy for Characterization of Regional Absorption Properties and Prospective Prediction of Plasma Concentrations Following Administration of New Modified Release Formulations , 2012, Pharmaceutical Research.

[94]  R. Suryanarayanan,et al.  Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose-citrate systems. , 2006, Journal of pharmaceutical sciences.

[95]  Cristina Maderuelo,et al.  Critical factors in the release of drugs from sustained release hydrophilic matrices. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[96]  L. Cartilier,et al.  Evaluation of cross-linked amylose press-coated tablets for sustained drug delivery , 1997 .

[97]  E. Brendel,et al.  Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[98]  J. Dressman,et al.  Biorelevant Media to Simulate Fluids in the Ascending Colon of Humans and Their Usefulness in Predicting Intracolonic Drug Solubility , 2010, Pharmaceutical Research.

[99]  Steven C Sutton,et al.  Companion animal physiology and dosage form performance. , 2004, Advanced drug delivery reviews.

[100]  E. Goddard.  On Polymer/Surfactant Interaction , 1991 .

[101]  M. H. Rubinstein,et al.  Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices , 1985 .

[102]  S. Joshi,et al.  Effect of SDS on the gelation of hydroxypropylmethylcellulose hydrogels , 2008 .

[103]  V. Lenaerts,et al.  Controlled release of theophylline from cross-linked amylose tablets , 1991 .

[104]  C. Rostron,et al.  Release of propranolol hydrochloride from matrix tablets containing hydroxypropylmethylcellulose K4M and carbopol 974 , 1994 .

[105]  Lynne S Taylor,et al.  Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[106]  Kiyohiko Sugano,et al.  Introduction to computational oral absorption simulation. , 2009, Expert opinion on drug metabolism & toxicology.

[107]  J. Remon,et al.  Modified starches as hydrophilic matrices for controlled oral delivery III. Evaluation of sustained-release theophylline formulations based on thermal modified starch matrices in dogs , 1990 .

[108]  M. Strømme,et al.  Finite element analysis of the release of slowly dissolving drugs from cylindrical matrix systems. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[109]  Matthew Roberts,et al.  The use of hypromellose in oral drug delivery , 2005, The Journal of pharmacy and pharmacology.

[110]  A. Barba,et al.  Controlled release from hydrogel-based solid matrices. A model accounting for water up-take, swelling and erosion. , 2011, International journal of pharmaceutics.

[111]  Peter Timmins,et al.  Pharmaceutical applications of confocal laser scanning microscopy: the physical characterisation of pharmaceutical systems. , 2007, Advanced drug delivery reviews.

[112]  Hans Lennernäs,et al.  Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. , 2007, Current drug metabolism.

[113]  J. Rosette,et al.  Pharmacokinetics and Pharmacodynamics of Tamsulosin in its Modified-Release and Oral Controlled Absorption System Formulations , 2010, Clinical pharmacokinetics.

[114]  A. Rajabi-Siahboomi,et al.  Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation. , 2008, International journal of pharmaceutics.

[115]  Clive G. Wilson.  The transit of dosage forms through the colon. , 2010, International journal of pharmaceutics.

[116]  L. Cartilier,et al.  Substituted amylose as a matrix for sustained-drug release: a biodegradation study. , 2001, International journal of pharmaceutics.

[117]  W Ewy,et al.  Model‐based Drug Development , 2007, Clinical pharmacology and therapeutics.

[118]  G. Duchateau,et al.  Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[119]  S. Davis,et al.  Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects , 1989 .

[120]  F. Onofre,et al.  Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets. , 2010, International journal of pharmaceutics.

[121]  C. Rostron,et al.  Hydroxypropylmethylcellulose matrix tablets containing propranolol hydrochloride and sodium dodecyl sulphate , 1991 .

[122]  H Lennernäs,et al.  Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[123]  A. Nokhodchi,et al.  Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose. , 2013, Colloids and surfaces. B, Biointerfaces.

[124]  E. Brendel,et al.  Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. , 2008, Clinical Therapeutics.

[125]  Ahmad Almaya,et al.  Optimization of LY545694 Tosylate Controlled Release Tablets Through Pharmacoscintigraphy , 2012, Pharmaceutical Research.

[126]  M. Levina,et al.  The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. , 2004, Journal of pharmaceutical sciences.

[127]  M. Levina,et al.  The Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems , 2007, Drug development and industrial pharmacy.

[128]  B. Perissutti,et al.  Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[129]  Sergei G. Kazarian,et al.  Simultaneous FTIR Spectroscopic Imaging and Visible Photography to Monitor Tablet Dissolution and Drug Release , 2008, Pharmaceutical Research.

[130]  S. Pygall,et al.  The use of in situ near infrared spectroscopy to provide mechanistic insights into gel layer development in HPMC hydrophilic matrices. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[131]  R. Nagaraju,et al.  Design and Development of Polyethylene Oxide Based Matrix Tablets for Verapamil Hydrochloride , 2013, Indian journal of pharmaceutical sciences.

[132]  Lawrence X. Yu,et al.  Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development , 2011, The AAPS Journal.

[133]  H. Ferraz,et al.  Bio-Dis and the Paddle Dissolution Apparatuses Applied to the Release Characterization of Ketoprofen from Hypromellose Matrices , 2009, AAPS PharmSciTech.

[134]  Sung-Joo Hwang,et al.  pH-independent sustained release matrix tablet containing doxazosin mesylate: Effect of citric acid , 2010, Archives of pharmacal research.

[135]  C. Fyfe,et al.  Quantitative NMR imaging study of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[136]  E. S. Ghaly,et al.  Kinetic release of theophylline from hydrophilic swellable matrices. , 1999, Drug development and industrial pharmacy.

[137]  R. Fassihi,et al.  Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation. , 1997, Journal of pharmaceutical sciences.

[138]  G. Amidon,et al.  Effects of Gravity on Gastric Emptying, Intestinal Transit, and Drug Absorption , 1991, Journal of clinical pharmacology.

[139]  J. Brasseur,et al.  A Novel in Vitro and Numerical Analysis of Shear-Induced Drug Release from Extended-Release Tablets in the Fed Stomach , 2005, Pharmaceutical Research.

[140]  Yuxi Jia,et al.  Mathematical modeling and finite element simulation of slow release of drugs using hydrogels as carriers with various drug concentration distributions. , 2013, Journal of pharmaceutical sciences.

[141]  S. Davis,et al.  The effect of anionic surfactants on the release of chlorpheniramine from a polymer matrix tablet , 1984 .

[142]  Gordon L. Amidon,et al.  Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.

[143]  M. A. Holgado,et al.  Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets , 1995 .

[144]  H. Kranz,et al.  Strategies to overcome pH-dependent solubility of weakly basic drugs by using different types of alginates. , 2008, Drug Development and Industrial Pharmacy.

[145]  S. B. Tiwari,et al.  Drug–Polymer Matrices for Extended Release , 2011 .

[146]  J. Sousa,et al.  New insights on the interaction between hydroxypropylmethyl cellulose and sodium dodecyl sulfate , 2011 .

[147]  J. Hardcastle,et al.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.

[148]  J. Gracia-Fadrique,et al.  The standard Gibbs energy of adsorption from the bulk at the surface of liquid mixtures: reinterpret , 2004 .

[149]  R. Espinoza,et al.  Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. , 2000, International journal of pharmaceutics.

[150]  T. Hino,et al.  Effect of nicotinamide on the properties of aqueous HPMC solutions. , 2001, International journal of pharmaceutics.

[151]  Carla Caramella,et al.  Rheological beheviour of hydrophilic polymers and drug release from erodible matrices , 1992 .

[152]  A. Rajabi-Siahboomi,et al.  Effect of Granulation Processing Parameters on Performance of Push-Pull Osmotic Pump Tablets of a Practically Water Insoluble Model Drug , 2012 .

[153]  L. Cartilier,et al.  Cross-linked amylose as matrix for drug controlled release. X-ray and FT-IR structural analysis , 1998 .

[154]  Jana Reinhard,et al.  Applied Surfactants Principles And Applications , 2016 .

[155]  C Caramella,et al.  On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[156]  Guideline on quality of oral modified release products 4 Draft 5 , 2012 .

[157]  Anette Müllertz,et al.  In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[158]  J. Barrett,et al.  Pharmacoscintigraphic Assessment of the Regional Drug Absorption of the Dual Angiotensin‐Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240, in Healthy Volunteers , 2003, Journal of clinical pharmacology.

[159]  S. Nilsson,et al.  Amphiphilic association of ibuprofen and two nonionic cellulose derivatives in aqueous solution. , 1999, Journal of pharmaceutical sciences.

[160]  J. Crison,et al.  Biowaiver approach for biopharmaceutics classification system class 3 compound metformin hydrochloride using in silico modeling. , 2012, Journal of pharmaceutical sciences.

[161]  C. Kohl.  The Importance of Gut Wall Metabolism in Determining Drug Bioavailability , 2008 .

[162]  F. Nekka,et al.  Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[163]  K. Kendall,et al.  Brittle—ductile trasitions in die compaction of sodium chloride , 1989 .

[164]  Ali Nokhodchi,et al.  Effect of ionic strength and pH of dissolution media on theophylline release from hypromellose matrix tablets—Apparatus USP III, simulated fasted and fed conditions , 2011 .

[165]  Per Holm,et al.  Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. , 2014, International journal of pharmaceutics.

[166]  A. Basit,et al.  Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery. , 2011, International journal of pharmaceutics.

[167]  V. Pillay,et al.  Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. , 1999, Journal of pharmaceutical sciences.

[168]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[169]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[170]  S. Nilsson.  Interactions between Water-Soluble Cellulose Derivatives and Surfactants. 1. The HPMC/SDS/Water System , 1995 .

[171]  M. Alpsten,et al.  Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon , 1996 .

[172]  John E. Hogan,et al.  Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets , 1987 .

[173]  A. Connor,et al.  Location, location, location: gastrointestinal delivery site and its impact on absorption. , 2012, Therapeutic delivery.

[174]  K. Beaumont,et al.  Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[175]  T. Chiba,et al.  A case of esophageal ulcer caused by alendronate sodium tablets. , 2011, Gastrointestinal endoscopy.

[176]  A S Hussain,et al.  Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[177]  C. Melia,et al.  Designing HPMC matrices with improved resistance to dissolved sugar. , 2010, International journal of pharmaceutics.

[178]  G. Amidon,et al.  Mechanistic understanding of food effects: water diffusivity in gastrointestinal tract is an important parameter for the prediction of disintegration of solid oral dosage forms. , 2013, Molecular pharmaceutics.

[179]  Hisakazu Sunada,et al.  Controlled-release of diclofenac sodium from wax matrix granule , 1996 .

[180]  Abu T M Serajuddin,et al.  Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form. , 2007, International journal of pharmaceutics.

[181]  Hatim S Alkhatib,et al.  Evaluation of hydrophilic matrix tablets based on Carbopol® 971P and low-viscosity sodium alginate for pH-independent controlled drug release , 2011, Drug development and industrial pharmacy.

[182]  H. Metz,et al.  Benchtop-NMR and MRI--a new analytical tool in drug delivery research. , 2008, International journal of pharmaceutics.

[183]  Renata Jachowicz,et al.  An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes. , 2008, Journal of pharmaceutical and biomedical analysis.

[184]  S. Davis,et al.  Influence of surfactants on drug release from hydroxypropylmethylcellulose matrices , 1988 .

[185]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[186]  Vinod P. Shah,et al.  FDA Guidance for Industry 1 Extended Release Solid Oral Dosage forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations , 1997 .

[187]  S. Davis,et al.  The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matrices , 1988 .

[188]  Paul Sheskey,et al.  Reworkability of Sustained-Release Tablet Formulations Containing HPMC Polymers , 1992 .

[189]  M. Repka,et al.  Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[190]  V. Sovilj,et al.  Influence of hydroxypropylmethyl cellulose-sodium dodecylsulfate interaction on the solution conductivity and viscosity and emulsion stability , 2006 .

[191]  N. Lordi,et al.  Drug release from compressed hydrophilic matrices. , 1968, Journal of pharmaceutical sciences.

[192]  Thomas Andersson,et al.  The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[193]  M Gibaldi,et al.  Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. , 1967, Journal of pharmaceutical sciences.

[194]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[195]  S. Waldman,et al.  Effects of Food on the Bioequivalence of Different Verapamil Sustained‐Release Formulations , 1995, Journal of clinical pharmacology.

[196]  Sodium Alginate.  Sodium alginate , 2020, Bollettino chimico farmaceutico.

[197]  L. Cartilier,et al.  Characterization of moving fronts in cross-linked amylose matrices by image analysis , 1996 .

[198]  Patrick J. Sinko,et al.  Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.

[199]  P. Blackshaw,et al.  Oesophageal transit, disintegration and gastric emptying of a film‐coated risedronate placebo tablet in gastro‐oesophageal reflux disease and normal control subjects , 2001, Alimentary pharmacology & therapeutics.

[200]  Mushir M. Ali,et al.  Statistical optimization and characterization of pH-independent extended-release drug delivery of cefpodoxime proxetil using Box–Behnken design , 2014 .

[201]  E. Shotton,et al.  Some observations on the ageing of sodium chloride compacts * , 1970, The Journal of pharmacy and pharmacology.

[202]  A. Nokhodchi,et al.  The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrices. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[203]  Lynne S. Taylor,et al.  Role of Salt and Excipient Properties on Disproportionation in the Solid-State , 2009, Pharmaceutical Research.

[204]  Bertil Abrahamsson,et al.  Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[205]  Franco Lombardo,et al.  Stabilization of Pharmaceuticals to Oxidative Degradation , 2002, Pharmaceutical development and technology.

[206]  J. E. Carless,et al.  Compression characteristics of some pharmaceutical materials. , 1967, Journal of pharmaceutical sciences.

[207]  P. Neuvonen,et al.  Effect of food on the bioavailability of oxybutynin from a controlled release tablet , 1996, European Journal of Clinical Pharmacology.

[208]  W. Pan,et al.  The Effect of Citric Acid Added to Hydroxypropyl Methylcellulose (HPMC) Matrix Tablets on the Release Profile of Vinpocetine , 2004, Drug development and industrial pharmacy.

[209]  A. Larsson,et al.  Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[210]  C. Rostron,et al.  The influence of drugs on the properties of gels and swelling characteristics of matrices containing methylcellulose or hydroxypropylmethylcellulose , 1993 .

[211]  E. Heymann,et al.  STUDIES ON THE LYOTROPIC SERIES. I: The Adsorption of Salts on Methylcellulose , 1937 .

[212]  Shiew-Mei Huang,et al.  Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice , 2012, Biopharmaceutics & drug disposition.

[213]  P. Zane,et al.  Use of the pentagastrin dog model to explore the food effects on formulations in early drug development. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[214]  A. Rajabi-Siahboomi,et al.  Water distribution studies within cellulose ethers using differential scanning calorimetry. 1. Effect of polymer molecular weight and drug addition. , 1999, Journal of pharmaceutical sciences.

[215]  H. Kanerva,et al.  Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[216]  Hans Lennernäs,et al.  Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. , 2009, Molecular pharmaceutics.

[217]  N. Shah,et al.  Effect of processing techniques in controlling the release rate and mechanical strength of hydroxypropyl methylcellulose based hydrogel matrices , 1996 .

[218]  A Rostami-Hodjegan,et al.  Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. , 2010, Current drug metabolism.

[219]  Jaehwi Lee,et al.  Development of a Directly Compressible Poly(Ethylene Oxide) Matrix for the Sustained-Release of Dihydrocodeine Bitartrate# , 2003, Drug development and industrial pharmacy.

[220]  S. Fitzpatrick,et al.  Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. , 2007, International journal of pharmaceutics.

[221]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[222]  P. Christian,et al.  Influence of meal weight and caloric content on gastric emptying of meals in man , 1984, Digestive Diseases and Sciences.

[223]  M. Roberts,et al.  Influence of ethanol on aspirin release from hypromellose matrices. , 2007, International journal of pharmaceutics.

[224]  P. Englezos,et al.  Kinetics of the aggregation of polyethylene oxide at temperatures above the polyethylene oxide–water cloud point temperature , 2002 .

[225]  L. Cartilier,et al.  Effect of some physical parameters on the swelling properties of cross-linked amylose matrices , 1998 .

[226]  J. R. Howard,et al.  Influence of some process variables on product properties for a hydrophilic matrix controlled release tablet , 1992 .

[227]  M. Camilleri,et al.  Activated charcoal as a potential radioactive marker for gastrointestinal studies. , 1998, Nuclear medicine communications.

[228]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[229]  M. H. Rubinstein,et al.  INFLUENCE OF pH ON THE DISSOLUTION OF PROMETHAZINE HYDROCHLORIDE FROM HYDROXYPROPYLMETHYLCELLULOSE CONTROLLED RELEASE TABLETS , 1985 .

[230]  Polymer mixtures , 1979, Nature.

[231]  C J Kim,et al.  Drug release from compressed hydrophilic POLYOX-WSR tablets. , 1995, Journal of pharmaceutical sciences.

[232]  J. Pritchard,et al.  Interrogating erosion-based drug liberation phenomena from hydrophilic matrices using near infrared (NIR) spectroscopy. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[233]  J. Ford,et al.  Thermal analysis of hydroxypropylmethylcellulose and methylcellulose: powders, gels and matrix tablets. , 1999, International journal of pharmaceutics.

[234]  R. C. Williams,et al.  Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist. , 1999, Pharmaceutical development and technology.

[235]  Kimberley A. Lentz,et al.  Current Methods for Predicting Human Food Effect , 2008, The AAPS Journal.

[236]  Alexander T. Florence,et al.  The adhesiveness of proprietary tablets and capsules to porcine oesophageal tissue , 1986 .

[237]  A. Larsson,et al.  Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[238]  B. Abrahamsson,et al.  Food effects on tablet disintegration. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[239]  R. Kinget,et al.  Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour , 1996 .

[240]  R. Fisher,et al.  The two-component stomach: effects of meal particle size on fundal and antral emptying , 2004, European Journal of Nuclear Medicine.

[241]  A. Nokhodchi,et al.  The role of various surfactants and fillers in controlling the release rate of theophylline from HPMC matrices , 1999 .

[242]  C. Liu,et al.  The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation , 1997 .

[243]  Bo Feng,et al.  In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System , 2008, Drug Metabolism and Disposition.

[244]  Y. Bustanji,et al.  Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[245]  S. Mitchell,et al.  A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets. , 2008, Journal of pharmaceutical sciences.

[246]  N A Peppas,et al.  Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[247]  C. Liu,et al.  Dissolution of diclofenac sodium from matrix tablets , 1992 .

[248]  H. Y. Park,et al.  Effect of pH on drug release from polysaccharide tablets. , 1998, Drug delivery.

[249]  John Crison,et al.  Predicting feasibility and characterizing performance of extended-release formulations using physiologically based pharmacokinetic modeling. , 2012, Therapeutic delivery.

[250]  R. Villalobos,et al.  Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices. , 2010, International journal of pharmaceutics.

[251]  R. Fassihi,et al.  An Investigation into the Erosion Behaviour of a High Drug‐load (85%) Particulate System Designed for an Extended‐release Matrix Tablet. Analysis of Erosion Kinetics in Conjunction with Variations in Lubrication, Porosity and Compaction Rate , 1999, The Journal of pharmacy and pharmacology.

[252]  N. Özdemir,et al.  Design of a controlled release osmotic pump system of ibuprofen , 1997 .

[253]  I. Wilding,et al.  Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. , 2000, British journal of clinical pharmacology.

[254]  J. Sjögren,et al.  Investigation of prandial effects on hydrophilic matrix tablets. , 1999, Drug development and industrial pharmacy.

[255]  J. Robinson.  Physiological Pharmaceutics—Barriers to Drug Absorption , 2003 .

[256]  K. Mäder,et al.  Monitoring drug delivery processes by EPR and related techniques--principles and applications. , 2005, Advanced drug delivery reviews.

[257]  J. Wells,et al.  Rheological synergism between ionic and non-ionic cellulose gums , 1982 .

[258]  John R. Mitchell,et al.  Structure and behaviour of hydrophilic matrix sustained release dosage forms: 1. The origin and mechanism of formation of gas bubbles in the hydrated surface layer , 1993 .

[259]  S. Hoag,et al.  Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. , 2004, Journal of pharmaceutical sciences.

[260]  V. Pillay,et al.  A novel approach for constant rate delivery of highly soluble bioactives from a simple monolithic system. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[261]  M. H. Rubinstein,et al.  Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose , 1985 .

[262]  C. Melia,et al.  Mechanisms of drug release in citrate buffered HPMC matrices. , 2009, International journal of pharmaceutics.

[263]  D. Craig,et al.  A thermorheological investigation into the gelation and phase separation of hydroxypropyl methylcellulose aqueous systems , 2002 .

[264]  K. Moribe,et al.  Improvement of HPMC tablet disintegration by the addition of inorganic salts. , 2008, Chemical & pharmaceutical bulletin.

[265]  David J Brayden,et al.  Comparison of methodologies for evaluating regional intestinal permeability. , 1997, Advances in experimental medicine and biology.

[266]  M. Hossain,et al.  Gastrointestinal Transit of Nondisintegrating, Nonerodible Oral Dosage Forms in Pigs , 1990, Pharmaceutical Research.

[267]  Paolo Colombo,et al.  Swelling-controlled release in hydrogel matrices for oral route , 1993 .

[268]  S. Kazarian,et al.  An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution , 2004 .

[269]  C. A. Bouman,et al.  Magnetic Resonance Imaging (MRI) , 2001 .

[270]  Karsten Mäder,et al.  Pharmaceutical applications of magnetic resonance imaging (MRI). , 2005, Advanced drug delivery reviews.

[271]  Martin Culen,et al.  Advances in dissolution instrumentation and their practical applications , 2014, Drug development and industrial pharmacy.

[272]  S. Nithiyanantham,et al.  Physico-chemical studies on some saccharides in aqueous cellulose solutions at different temperatures – Acoustical and FTIR analysis , 2014 .

[273]  R. Williams,et al.  Investigation of Excipient Type and Level on Drug Release from Controlled Release Tablets Containing HPMC , 2002, Pharmaceutical development and technology.

[274]  Stephen P. Morgan,et al.  Magnetic Resonance Imaging Analysis of Molecular Mobility during Dissolution of Poly(vinyl alcohol) in Water , 1999 .

[275]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[276]  D. J. Phillips,et al.  Toward Biorelevant Dissolution: Application of a Biphasic Dissolution Model as a Discriminating Tool for HPMC Matrices Containing a Model BCS Class II Drug , 2012 .

[277]  I. Wilding,et al.  Systemic Availability of the Active Metabolite Hydroxy‐Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract , 2007, Journal of clinical pharmacology.

[278]  P. Schmidt,et al.  Surface acidity of solid pharmaceutical excipients. I: Determination of the surface acidity , 1994 .

[279]  H. Metz,et al.  Application of electron paramagnetic resonance (EPR) spectroscopy and imaging in drug delivery research - chances and challenges. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[280]  L. Picton,et al.  Saccharide effect on the LCST property of a polyether: Influence of structure and length , 2013 .

[281]  A. Larsson,et al.  The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[282]  J. Tack,et al.  Parallel Monitoring of Plasma and Intraluminal Drug Concentrations in Man After Oral Administration of Fosamprenavir in the Fasted and Fed State , 2007, Pharmaceutical Research.

[283]  H. Jones,et al.  Application of Physiologically Based Pharmacokinetic Modeling to Understanding the Clinical Pharmacokinetics of UK-369,003 , 2011, Drug Metabolism and Disposition.

[284]  E. Galia,et al.  Opioid extended-release tablets with improved tamper-resistant properties , 2012, Expert opinion on drug delivery.

[285]  Michael B. Bolger,et al.  Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data , 2009, The AAPS Journal.

[286]  A. Serajuddin,et al.  Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method. , 2008, Journal of pharmaceutical sciences.

[287]  J. Moore,et al.  Circadian variation in gastric emptying of meals in humans. , 1987, Gastroenterology.

[288]  C. Rostron,et al.  Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropylmethylcellulose K4M and carbopol 974. , 1996, Journal of pharmaceutical sciences.

[289]  D. J. Phillips,et al.  Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems , 2012, The Journal of pharmacy and pharmacology.

[290]  P. Buri,et al.  Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices , 1990 .

[291]  Abdul W Basit,et al.  Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. , 2009, International journal of pharmaceutics.

[292]  Sandip B. Tiwari,et al.  Applications of Complementary Polymers in HPMC Hydrophilic Extended Release Matrices , 2009 .

[293]  S. Nilsson,et al.  Influence of counterion on the interaction of dodecyl sulfates and cellulose ethers. , 2002, Journal of Colloid and Interface Science.

[294]  G. Amidon,et al.  Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms , 2008, Pharmaceutical Research.

[295]  Neil Parrott,et al.  Applications of physiologically based absorption models in drug discovery and development. , 2008, Molecular pharmaceutics.

[296]  M. Stefansson,et al.  Interactions between sodium dodecyl sulphate and non-ionic cellulose derivatives studied by size exclusion chromatography with online multi-angle light scattering and refractometric detection. , 2005, Journal of chromatography. A.

[297]  S. Davis,et al.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. , 1988, British journal of clinical pharmacology.

[298]  R Kinget,et al.  Design and evaluation of two-phase partition-dissolution method and its use in evaluating artemisinin tablets. , 1996, Journal of pharmaceutical sciences.

[299]  H. Grondey,et al.  NMR imaging investigations of drug delivery devices using a flow-through USP dissolution apparatus. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[300]  B. Sigel,et al.  The Stomach , 1993, Springer Berlin Heidelberg.

[301]  P. York,et al.  Microenvironmental pH control of drug dissolution , 1989 .

[302]  L Hendeles,et al.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.

[303]  Hirst,et al.  Development of a new engineering-based capsule for human drug absorption studies. , 2000, Pharmaceutical science & technology today.

[304]  A. Larsson,et al.  New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide). , 2007, International journal of pharmaceutics.

[305]  G. Lamberti,et al.  Drug release from matrix systems: analysis by finite element methods , 2012 .

[306]  J. Ketolainen,et al.  Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets. , 2009, Journal of pharmaceutical sciences.

[307]  A. Stergachis,et al.  Incidence of adverse oesophageal and gastric events in alendronate users , 2000, Pharmacoepidemiology and drug safety.

[308]  C. J. Knill,et al.  Modified gums: Approaches and applications in drug delivery , 2011 .

[309]  Y. Lam,et al.  Thermoreversible gelation of hydroxypropylmethylcellulose in simulated body fluids , 2008 .

[310]  Margareth R. C. Marques.  Dissolution Media Simulating Fasted and Fed States , 2004 .

[311]  S. Baumgartner,et al.  Effect of calcium ions on the gelling and drug release characteristics of xanthan matrix tablets. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[312]  P. Griffiths,et al.  Solution interactions of diclofenac sodium and meclofenamic acid sodium with hydroxypropyl methylcellulose (HPMC). , 2011, International journal of pharmaceutics.

[313]  G. Aldini,et al.  Electron Paramagnetic Resonance (EPR) Spectroscopy: A Versatile and Powerful Tool in Pharmaceutical and Biomedical Analysis , 2006 .

[314]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[315]  Kabir-ud-din,et al.  Effect of inorganic salts on the clouding behavior of hydroxypropyl methyl cellulose in presence of amphiphilic drugs. , 2013, Colloids and surfaces. B, Biointerfaces.

[316]  J. Dressman,et al.  Biorelevant Dissolution Media Simulating the Proximal Human Gastrointestinal Tract: An Update , 2009 .

[317]  A. Basit,et al.  Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[318]  Lei Li,et al.  Mapping neutral microclimate pH in PLGA microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[319]  F. Podczeck,et al.  The use of formulation technology to assess regional gastrointestinal drug absorption in humans. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[320]  Jianing Zeng,et al.  Development of oral extended release formulations of 6‐hydroxybuspirone , 2012, Biopharmaceutics & drug disposition.

[321]  S. Baveja,et al.  Sustained release tablet formulation of centperazine , 1986 .

[322]  M. Rajaniemi,et al.  Effect of dosage form and formulation factors on the adherence of drugs to the esophagus. , 1983, Journal of pharmaceutical sciences.

[323]  E. Rinaki,et al.  The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. , 2003, International journal of pharmaceutics.

[324]  Hyunyoung Jeong,et al.  Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans , 2000, Pharmaceutical Research.

[325]  H. Kranz,et al.  Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[326]  Paolo Colombo,et al.  Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport , 1996 .

[327]  C. Melia,et al.  Investigating in vitro drug release mechanisms inside dosage forms. Monitoring liquid ingress in HPMC hydrophilic matrices using confocal microscopy. , 1997, Advances in experimental medicine and biology.

[328]  Waseem Kaialy,et al.  Aqueous and hydro-alcoholic media effects on polyols. , 2013, Colloids and surfaces. B, Biointerfaces.

[329]  N. Lordi,et al.  Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. , 1966, Journal of pharmaceutical sciences.

[330]  H. E. Huber,et al.  Utilization of hydrophilic gums for the control of drug release from tablet formulations. I. Disintegration and dissolution behavior. , 1966, Journal of pharmaceutical sciences.

[331]  Denita Winstead,et al.  Determination of water penetration and drug concentration profiles in HPMC-based matrix tablets by near infrared chemical imaging. , 2010, Journal of pharmaceutical sciences.

[332]  G. Alebiowu,et al.  Compressional Characteristics of Native and Pregelatinized Forms of Sorghum, Plantain, and Corn Starches and the Mechanical Properties of Their Tablets , 2002, Drug development and industrial pharmacy.

[333]  W. Weitschies,et al.  A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[334]  A. Basit,et al.  Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol. , 2008, International journal of pharmaceutics.

[335]  Hans Leuenberger,et al.  The application of percolation theory in powder technology , 1999 .

[336]  L. Marciani,et al.  Assessment of antral grinding of a model solid meal with echo-planar imaging. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[337]  R. Marchessault,et al.  Mechanical properties and structure of swollen crosslinked high amylose starch tablets , 2002 .

[338]  Alan M. Smith,et al.  Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices. , 2014, International journal of pharmaceutics.

[339]  I. Caraballo,et al.  Study of critical points of drugs with different solubilities in hydrophilic matrices. , 2010, International journal of pharmaceutics.

[340]  P. Tran,et al.  Controlled Release Systems Containing Solid Dispersions: Strategies and Mechanisms , 2011, Pharmaceutical Research.

[341]  C. Melia,et al.  The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug. , 2010, International journal of pharmaceutics.

[342]  M. Alpsten,et al.  Absorption, Gastrointestinal Transit, and Tablet Erosion of Felodipine Extended-Release (ER) Tablets , 1993, Pharmaceutical Research.

[343]  Y. Lam,et al.  Effects of salts in the Hofmeister series and solvent isotopes on the gelation mechanisms for hydroxypropylmethylcellulose hydrogels , 2008 .

[344]  R. Cameron,et al.  Synchrotron X-ray microtomographic study of tablet swelling. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[345]  Jaap van der Weerd,et al.  Combined approach of FTIR imaging and conventional dissolution tests applied to drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[346]  Matej Horvat,et al.  Correlating Cellulose Derivative Intrinsic Viscosity with Mechanical Susceptibility of Swollen Hydrophilic Matrix Tablets , 2012, AAPS PharmSciTech.

[347]  R. Gurny,et al.  Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. , 2006, International journal of pharmaceutics.

[348]  Richard Bowtell,et al.  Magnetic resonance imaging of controlled release pharmaceutical dosage forms , 1998 .

[349]  M Rowland,et al.  The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review , 2012, Clinical pharmacology and therapeutics.

[350]  P. R. Nixon,et al.  Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. , 1996, Journal of Pharmacy and Science.

[351]  V. Sinha,et al.  High molecular weight poly(ethylene oxide)-based drug delivery systems : Part I: Hydrogels and hydrophilic matrix systems , 2005 .

[352]  W I Higuchi,et al.  Investigation of factors influencing release of solid drug dispersed in inert matrices. , 1966, Journal of pharmaceutical sciences.

[353]  L. Gladden,et al.  In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[354]  C. Kim.  Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. , 1998, Drug development and industrial pharmacy.

[355]  E. Heymann.  Studies on sol-gel transformations. I. The inverse sol-gel transformation of methylcellulose in water , 1935 .

[356]  A. Alavi,et al.  The effect of meal energy content on gastric emptying. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[357]  M. Alpsten,et al.  Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[358]  U. Cobet,et al.  The use of ultrasound and penetrometer to characterize the advancement of swelling and eroding fronts in HPMC matrices , 1998 .

[359]  Xinyuan Zhang,et al.  The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation. , 2011, International journal of pharmaceutics.

[360]  M. Karlsson,et al.  A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations , 2012, Pharmaceutical Research.

[361]  Jaspreet Singh,et al.  Factors influencing the physico-chemical, morphological, thermal and rheological properties of some chemically modified starches for food applications--A review , 2007 .

[362]  James A. Rogers,et al.  Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test , 1997 .

[363]  K. Takada,et al.  Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[364]  P Timmins,et al.  Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. , 1997, Pharmaceutical development and technology.

[365]  Y. Seta,et al.  Evaluation of the mechanical destructive force in the stomach of dog. , 2001, International journal of pharmaceutics.

[366]  Lutz Trahms,et al.  Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[367]  S. Baveja,et al.  Zero-order release hydrophilic matrix tablets of β-adrenergic blockers , 1987 .

[368]  A. Urtti,et al.  Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[369]  S. Alex,et al.  Mucoadhesive properties of cross-linked high amylose starch derivatives. , 2006, International journal of biological macromolecules.

[370]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[371]  Richard Bowtell,et al.  Structure and behaviour in hydrophilic matrix sustained release dosage forms: 2. NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration , 1994 .

[372]  C. Melia,et al.  The effect of sucrose and salts in combination on the drug release behaviour of an HPMC matrix. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[373]  N A Peppas,et al.  Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. , 2000, International journal of pharmaceutics.

[374]  M. Fathi,et al.  Zero-Order Release Formulation of Oxprenolol Hydrochloride with Swelling and Erosion Control , 1989, Pharmaceutical Research.

[375]  P. R. Nixon,et al.  Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. , 1995, Journal of pharmaceutical sciences.

[376]  Han van de Waterbeemd,et al.  Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability , 2003 .

[377]  C. Melia,et al.  The influence of substituted phenols on the sol:gel transition of hydroxypropyl methylcellulose (HPMC) aqueous solutions. , 2014, Carbohydrate polymers.

[378]  H. Yuasa,et al.  Suppression of Agglomeration in Fluidized Bed Coating. III. Hofmeister Series in Suppression of Particle Agglomeration , 1999, Pharmaceutical Research.

[379]  Göran Frenning,et al.  Modelling drug release from inert matrix systems: from moving-boundary to continuous-field descriptions. , 2011, International journal of pharmaceutics.

[380]  Ali Nokhodchi,et al.  The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropylmethylcellulose 2208 , 1996 .

[381]  I. Wilding,et al.  The role of γ-scintigraphy in oral drug delivery , 1991 .

[382]  H Lennernäs,et al.  Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.

[383]  R. Gurny,et al.  Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[384]  M. Vlachou,et al.  Image analysis studies of dimensional changes in swellable hydrophilic polymer matrices , 2004 .

[385]  S. Hoag,et al.  Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. , 2006, Journal of pharmaceutical sciences.

[386]  S. Samani,et al.  The effect of polymer blends on release profiles of diclofenac sodium from matrices. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[387]  J. Elashoff,et al.  Effects of viscosity and fluid outflow on postcibal gastric emptying of solids. , 1986, The American journal of physiology.

[388]  R. Chokshi,et al.  Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. , 2008, Journal of pharmaceutical sciences.

[389]  Martyn C. Davies,et al.  Structure and Behavior in Hydrophilic Matrix Sustained Release Dosage Forms: 4. Studies of Water Mobility and Diffusion Coefficients in the Gel Layer of HPMC Tablets Using NMR Imaging , 1996, Pharmaceutical Research.

[390]  J. Sousa,et al.  Aggregation and gelation in hydroxypropylmethyl cellulose aqueous solutions. , 2008, Journal of colloid and interface science.

[391]  C. Melia,et al.  Microstructural imaging of early gel layer formation in HPMC matrices. , 2006, Journal of pharmaceutical sciences.

[392]  J. Roush.  The role of the stomach in drug absorption as observed via absorption rate analysis. , 2014, International journal of pharmaceutics.

[393]  J. Fallingborg,et al.  Intraluminal pH of the human gastrointestinal tract. , 1999, Danish medical bulletin.

[394]  G. Amidon,et al.  Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. , 1986, Journal of pharmaceutical sciences.

[395]  S. Saito.  Binding of surfactants by polymers , 1960 .

[396]  S. Malamataris,et al.  Effect of particle size and sorbed moisture on the tensile strength of some tableted hydroxypropyl methylcellulose (HPMC) polymers , 1994 .

[397]  L. Maggi,et al.  Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. , 2002, Biomaterials.

[398]  J. Robinson,et al.  Some biological issues in oral, controlled drug delivery , 1987 .

[399]  Lee Ann Hodges,et al.  In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[400]  I. Wilding,et al.  A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[401]  J. Remon,et al.  Performance of a modified starch hydrophilic matrix for the sustained release of theophylline in healthy volunteers. , 1992, Journal of pharmaceutical sciences.

[402]  P. Tran,et al.  Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[403]  Robert Langer,et al.  Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.

[404]  Leopoldo Villafuerte-Robles,et al.  Influence of admixed lactose on pelanserin hydrochloride release from hydroxypropyl methylcellulose matrix tablets , 1999 .

[405]  Bruno C. Hancock,et al.  Ionization States in the Microenvironment of Solid Dosage Forms: Effect of Formulation Variables and Processing , 2006, Pharmaceutical Research.

[406]  J. Siepmann,et al.  pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[407]  H. Fukui,et al.  Preparation of nifedipine-hydroxypropylmethylcellulose phthalate solid dispersion by twin screw extruder and its evaluation , 1996 .

[408]  Malcolm Rowland,et al.  Physiologically-based pharmacokinetics in drug development and regulatory science. , 2011, Annual review of pharmacology and toxicology.

[409]  L. Gladden,et al.  Quantitative ultra-fast MRI of HPMC swelling and dissolution. , 2010, Journal of pharmaceutical sciences.

[410]  G L Amidon,et al.  The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. , 1990, Gastroenterology.

[411]  Malcolm Rowland,et al.  PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.

[412]  K. Picker-Freyer,et al.  Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[413]  S. Rossi,et al.  On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum , 1993 .

[414]  L. Marciani,et al.  Delayed gastric emptying and reduced postprandial small bowel water content of equicaloric whole meal bread versus rice meals in healthy subjects: novel MRI insights , 2013, European Journal of Clinical Nutrition.

[415]  J. Moore,et al.  Circadian Rhythm of Gastric Acid Secretion in Man , 1970, Nature.

[416]  R. Bodmeier,et al.  Effect of ion exchange resins on the drug release from matrix tablets. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[417]  R. Hardy,et al.  Effect of Drug Solubility on Polymer Hydration and Drug Dissolution from Polyethylene Oxide (PEO) Matrix Tablets , 2008, AAPS PharmSciTech.

[418]  E. Morris,et al.  Thermogelation of methylcellulose. Part I: molecular structures and processes , 1993 .

[419]  M. H. Rubinstein,et al.  Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices containing ethylcellulose , 1996 .

[420]  Bart Hens,et al.  A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[421]  E. Brendel,et al.  Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union. , 2006, International journal of clinical pharmacology and therapeutics.

[422]  C. Fyfe,et al.  Investigation of Hydrogel Formation from Hydroxypropylmethylcellulose (HPMC) by NMR Spectroscopy and NMR Imaging Techniques , 1997 .

[423]  M. Turkoğlu,et al.  Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers. , 2009, International journal of pharmaceutics.

[424]  M. Kamil,et al.  Solution Behavior of Nonionic Polymer Hydroxypropylmethyl Cellulose: Effect of Salts on the Energetics at the Cloud Point , 2011 .

[425]  J. Dressman,et al.  Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update , 2008, Pharmaceutical Research.

[426]  J. Elashoff,et al.  Human postprandial gastric emptying of 1-3-millimeter spheres. , 1988, Gastroenterology.

[427]  Paolo Colombo,et al.  Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects , 1994 .

[428]  G. Crean,et al.  Comparison of gastric body and antral pH: a 24 hour ambulatory study in healthy volunteers. , 1989, Gut.

[429]  M. C. Bonferoni,et al.  Development of Oral Controlled Release Tablet Formulations Based on Diltiazem–Carrageenan Complex , 2004, Pharmaceutical development and technology.

[430]  Amarjit Singh,et al.  Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry , 1988 .

[431]  A G Renwick,et al.  The pharmacokinetics of oral nifedipine--a population study. , 1988, British journal of clinical pharmacology.

[432]  Sung-Joo Hwang,et al.  Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia , 2009, Archives of pharmacal research.

[433]  C. Melia,et al.  The extended release properties of HPMC matrices in the presence of dietary sugars. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[434]  A. Krishnan,et al.  Traube-Rule Interpretation of Protein Adsorption at the Liquid−Vapor Interface† , 2003 .

[435]  G. Amidon,et al.  Gastric emptying of nondigestible solids in dogs: a hydrodynamic correlation. , 1990, The American journal of physiology.

[436]  Jooil Kim,et al.  Food-Effect Bioavailability and Fed Bioequivalence Studies , 2005 .

[437]  B. A. Johnson,et al.  Use of the Antioxidant BHT in Asymmetric Membrane Tablet Coatings to Stabilize the Core to the Acid Catalyzed Peroxide Oxidation of a Thioether Drug , 2005, Pharmaceutical development and technology.

[438]  H. Hasselbalch,et al.  Oesophageal transit of six commonly used tablets and capsules. , 1982, British medical journal.

[439]  L. Villafuerte-Robles,et al.  Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process. , 2003, International journal of pharmaceutics.

[440]  Hong Wen,et al.  Systematical approach of formulation and process development using roller compaction. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[441]  M. H. Rubinstein,et al.  The Influence of Moisture Content on the Consolidation Properties of Hydroxypropylmethylcellulose K4M (HPMC 2208) , 1996, The Journal of pharmacy and pharmacology.

[442]  Werner Weitschies,et al.  Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditions , 2010, Drug development and industrial pharmacy.

[443]  A. Larsson,et al.  Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[444]  P. Kulinowski,et al.  Magnetic Resonance Imaging and Image Analysis for Assessment of HPMC Matrix Tablets Structural Evolution in USP Apparatus 4 , 2010, Pharmaceutical Research.

[445]  Stephen Hibberd,et al.  Measurement and Mapping of pH in Hydrating Pharmaceutical Pellets Using Confocal Laser Scanning Microscopy , 2002, Pharmaceutical Research.

[446]  T. Bhardwaj,et al.  Natural Gums and Modified Natural Gums as Sustained-Release Carriers , 2000, Drug development and industrial pharmacy.

[447]  J. Dressman,et al.  Comparison of Canine and Human Gastrointestinal Physiology , 1986, Pharmaceutical Research.

[448]  Krister Holmberg,et al.  Handbook of applied surface and colloid chemistry , 2002 .

[449]  Rolf Daniels,et al.  Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[450]  R. Spiller,et al.  Impaired oesophageal transit of capsule versus tablet formulations in the elderly. , 1994, Gut.

[451]  K. Mäder,et al.  Monitoring of internal pH gradients within multi-layer tablets by optical methods and EPR imaging. , 2011, International journal of pharmaceutics.

[452]  G. Tucker,et al.  The Effect of Ethanol on the Release of Opioids from Oral Prolonged-Release Preparations , 2007, Drug development and industrial pharmacy.

[453]  R. Fassihi,et al.  Analysis of macromolecular changes and drug release from hydrophilic matrix systems. , 2005, International journal of pharmaceutics.

[454]  M. L. González-Rodríguez,et al.  Design and evaluation of a new central core matrix tablet , 1997 .

[455]  L. Maggi,et al.  Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. , 2007, International journal of pharmaceutics.

[456]  R. Schall,et al.  The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast. , 2002, British journal of clinical pharmacology.

[457]  Micaela B. Reddy,et al.  Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible , 2011, Biopharmaceutics & drug disposition.

[458]  I. Wilding,et al.  Gastrointestinal transit of a matrix tablet formulation : comparison of canine and human data , 1993 .

[459]  J. Mucklow,et al.  Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.

[460]  Ken-ichi Yamamoto,et al.  Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methylcellulose sustained release tablets , 1996 .

[461]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .

[462]  A. Rajabi-Siahboomi,et al.  Polymer Percolation Threshold in HPMC Extended Release Formulation of Carbamazepine and Verapamil HCl , 2010, AAPS PharmSciTech.

[463]  Robert Gurny,et al.  Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound. , 2008, Drug development and industrial pharmacy.

[464]  Monique Alric,et al.  A Dynamic Artificial Gastrointestinal System for Studying the Behavior of Orally Administered Drug Dosage Forms Under Various Physiological Conditions , 2004, Pharmaceutical Research.

[465]  Robert L. Davidson,et al.  Handbook of Water Soluble Gums and Resins , 1980 .

[466]  W. Weitschies,et al.  Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution. , 2013, Molecular pharmaceutics.

[467]  A. Larsson,et al.  Influence of Different Polymer Types on the Overall Release Mechanism in Hydrophilic Matrix Tablets , 2009, Molecules.

[468]  T. H. Wilson,et al.  The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface , 1954, The Journal of physiology.

[469]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[470]  P. Buri,et al.  Cellulose Matrices for Zero-Order Release of Soluble Drugs , 1988 .

[471]  P. Kearney,et al.  The effects of mucus glycoproteins on the bioavailability of tetracycline. III. Everted gut studies , 1987 .

[472]  A. Sakr,et al.  Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[473]  J. Virjee,et al.  The effect of formulation on oesophageal transit , 1985, The Journal of pharmacy and pharmacology.

[474]  M. Varma,et al.  Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[475]  T. Rades,et al.  Characterization of glass solutions of poorly water‐soluble drugs produced by melt extrusion with hydrophilic amorphous polymers , 2001, The Journal of pharmacy and pharmacology.

[476]  Application of a modelling system in the formulation of extended release hydrophilic matrices , .

[477]  Nicholas A Peppas,et al.  Higuchi equation: derivation, applications, use and misuse. , 2011, International journal of pharmaceutics.

[478]  Y. Seta,et al.  A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. , 2000, International journal of pharmaceutics.

[479]  Steven C Sutton,et al.  The use of gastrointestinal intubation studies for controlled release development. , 2009, British journal of clinical pharmacology.

[480]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[481]  Ali Nokhodchi,et al.  The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. , 2013, Colloids and surfaces. B, Biointerfaces.

[482]  R. Kjellander,et al.  Water structure and changes in thermal stability of the system poly(ethylene oxide)–water , 1981 .

[483]  A. Basit,et al.  Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. , 2010, International journal of pharmaceutics.

[484]  Werner Weitschies,et al.  Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[485]  K. P. Nott.  Magnetic resonance imaging of tablet dissolution. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[486]  Larry L. Augsburger,et al.  A Novel Nuclear Magnetic Resonance (NMR) Imaging Method for Measuring the Water Front Penetration Rate in Hydrophilic Polymer Matrix Capsule Plugs and Its Role in Drug Release , 1994, Pharmaceutical Research.

[487]  H. Lennernäs,et al.  Oral Drug Absorption: Prediction and Assessment , 2000 .

[488]  E. D. Klug.  Some properties of water-soluble hydroxyalkyl celluloses and their derivatives , 2007 .

[489]  V. Lenaerts,et al.  Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[490]  F. Veiga,et al.  Influence of Technological Variables on the Release of Theophylline from Hydrophilic Matrix Tablets , 1997 .

[491]  Susan A. Barker,et al.  Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data , 2011, AAPS PharmSciTech.

[492]  H. Freund,et al.  Historical overview. , 2021, Advances in neurology.

[493]  T. Okabe,et al.  Dissolution mechanism of diclofenac sodium from wax matrix granules. , 1997, Journal of pharmaceutical sciences.

[494]  John W. Skoug,et al.  In Vitro and in Vivo Evaluation of Whole and Half Tablets of Sustained-Release Adinazolam Mesylate , 1991, Pharmaceutical Research.

[495]  S. S. Davis,et al.  Gastrointestinal transit of dosage forms in the pig , 2001, The Journal of pharmacy and pharmacology.

[496]  I. Wilding,et al.  Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315. , 2009, Journal of pharmaceutical sciences.

[497]  David F. Evans,et al.  Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and pH monitoring , 1987 .

[498]  O. Corrigan,et al.  Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices--influence of agitation rate and dissolution medium composition. , 2004, International journal of pharmaceutics.

[499]  A. Rajabi-Siahboomi,et al.  Water distribution studies within cellulose ethers using differential scanning calorimetry. 2. Effect of polymer substitution type and drug addition. , 1999, Journal of pharmaceutical sciences.

[500]  K. E. Gabr.  Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets , 1992 .

[501]  C. Roberts,et al.  Effect of delayed esophageal transit on acetaminophen absorption , 1985, Clinical pharmacology and therapeutics.

[502]  J. Siepmann,et al.  Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[503]  Guideline on the pharmacokinetic and clinical evaluation 4 of modified release dosage forms , 2013 .

[504]  L. Cartilier,et al.  Cross-linked high amylose starch for controlled release of drugs: recent advances. , 1998, Journal of controlled release : official journal of the Controlled Release Society.